# Sofia Dahoune

> Sofia Dahoune is a Series A investor at Elaia (Paris) backing Biotechnology and Power Grid. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Elaia](https://shizune.co/investors/profile/elaia-partners)
- Location: Paris, France
- Total investments: 5
- Last investment: Jun 2026
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sofiadahoune

Sofia Dahoune is a Series A investor at Elaia in Paris focused on Biotechnology and Power Grid. VC Investment Manager at Bpifrance

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Power Grid | 1 | 20% |
| Life Science | 1 | 20% |
| Pharmaceutical | 1 | 20% |
| Machine Learning | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Seed | 1 | 20% |
| Pre-Seed | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 2 | 40% |
| Luxembourg | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Graph Therapeutics | Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. | $5M | Seed | Jun 22, 2026 |  |
| TerraSpark | TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects. | $5.8M | Pre-Seed | Mar 30, 2026 |  |
| AQEMIA | AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $19.5M | Series A | Oct 19, 2022 |  |
| Alice & Bob | Alice&Bob build Universal, Error-free, Quantum Computers to help industries and researchers solve the hardest problems. | $29.9M | Series A | Mar 09, 2022 |  |
| AQEMIA | AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $10.8M | Series A | May 01, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 2 deals together
- [better ventures](https://shizune.co/investors/profile/better-ventures-9d06) — VC Fund, 1 deal together
- [BREEGA](https://shizune.co/investors/profile/breega-capital) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together
- [Hansmen Group](https://shizune.co/investors/profile/hansmen-group) — VC Fund, 1 deal together

## About Elaia

VC Fund · Paris, France

Elaia is a European full stack tech and deep tech investor. We partner with ambitious entrepreneurs from inception to leadership, helping them navigate the future and the unknown. For over twenty years, we have combined deep scientific and technological expertise with decades of operational experience to back those building tomorrow. Our jointventure with Lazard, Lazard Elaia Capital, enables us to support exceptional founders at any stage. From our offices in Paris, Barcelona and Tel Aviv, we have been active partners with over 100 startups including Criteo, Mirakl, Shift Technology, AQEMIA and Alice & Bob.

5 contacts available at Elaia.

| Name | Title | Profile |
| --- | --- | --- |
| Louisa Mesnard | CMO & Head of Sustainability | https://shizune.co/investors/profile/louisa-mesnard |
| Philippe Gire | Partner | https://shizune.co/investors/profile/philippe-gire |
| Sofia Dahoune | Investment Manager | https://shizune.co/investors/profile/sofia-dahoune |
| Anne-Sophie Carrese | Managing Partner | https://shizune.co/investors/profile/anne-sophie-carr%C3%A8se |
| Céline Passedouet | Investment Director | https://shizune.co/investors/profile/c%C3%A9line-passedouet |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sofia Dahoune invest in?

Sofia Dahoune invests primarily in Biotechnology, Power Grid and Life Science startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sofia Dahoune last invest?

The most recent investment recorded for Sofia Dahoune closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co